LINC02559

Across TCGA pan-cancer cohorts, LINC02559 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated LINC02559 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher LINC02559 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02559 expression acts as an unfavorable survival marker, although some lineages such as OV and PAAD show a favorable association.

UCS, CESC, and THCA are the cancer types where LINC02559 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	IV	0.132	0.718	.002	84	view →
CESC	OS	Tertile	III,IV	0.091	0.755	<.001	72	view →
THCA	OS	Tertile	All	0.209	0.938	<.001	66	view →
STAD	OS	Tertile	All	0.498	0.699	.005	63	view →
OV	DFS	Tertile	III,IV	0.535	0.361	.024	36	view →
PAAD	DFS	Tertile	All	0.625	0.277	.003	33	view →
BRCA	DFS	Tertile	III,IV	0.924	0.764	.010	27	view →
LGG	OS	Tertile	All	0.585	0.389	.002	25	view →
LAML	DFS	Quartile	All	0.522	0.337	.028	18	view →
MESO	OS	Tertile	IV	0.077	0.592	.019	18	view →
THYM	DFS	Tertile	III,IV	0.205	0.774	.007	12	view →
KIRP	DFS	Tertile	All	0.461	0.626	.032	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

LINC02559–UCS (DFS)

Open the UCS breakdown →